COVID-19

Program Language

English

Meeting type

Virtual Meeting

Organizer

Leveraging mRNA Technology Workshop 2024

General

What's New

The program for the Leveraging mRNA Technology Workshop 2024 is currently under development and will be announced in due time.
To stay updated on the relevant developments, make sure you are signed up for our newsletter.

About this Program

The breakthrough of the mRNA platform enabled the development of SARS-CoV-2 vaccines at an unprecedented pace, heralding a new era for the prevention of other infectious diseases. It opened new avenues to rethink long-standing scientific questions, such as vaccines for hepatitis C and HIV, or neglected tropical diseases, in a scalable and affordable manner.

Beyond prophylaxis, mRNA technology holds promise for treating many rare and common clinical indications. One size does not fit all, and several challenges remain towards achieving broad clinical relevance, including effective targeted delivery, optimal expression, and immunological properties.

Leveraging mRNA technology beyond its current clinical applications relies on fostering scientific discussion to catalyze new concepts and cross-disciplinary innovative solutions. To this end, we propose a forum gathering leading experts from academic and industry settings to facilitate focused scientific interchange on niche topics that are the subject of intensive research yet underrepresented at major international meetings.

Starting from September 2024, Quarterly Online Editions Include

mRNA Cancer Vaccines
Delivery of Antibodies and Other Biologics by mRNA
mRNA Delivery Systems
mRNA Vaccines for Respiratory Diseases
Mechanism of Action of mRNA Vaccines
mRNA for Gene Editing and Cell-Based Therapy

Program Directors

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Daniel Kuritzkes, MD

Brigham and Women's Hospital / Harvard Medical School, United States

General Information

Who Should Attend?

- Researchers in academic institutions / hospitals (basic, translational, clinical);
- Researchers from the pharmaceutical and biotech industry.

Workshop Objectives

The workshop aims to:

- Provide a focused forum for scientific exchange addressing remaining challenges for the broader clinical application of mRNA technology;
- Provide a platform for the presentation of latest data and innovative solutions;
- Stimulate cross-disciplinary discussion, collaboration, and evolution of new concepts.

Learning Objectives

After participating in this activity, participants will be able to:

- Summarize the latest advancement in mRNA and lipid nanoparticle biotechnology;
- Reflect on the latest advancement in design and pre-clinical evaluations of novel vaccine candidates;
- Describe clinical data supporting the use of mRNA-based vaccines for infectious diseases;
- Comprehend key clinical considerations for the use of mRNA-based therapeutics in different populations and healthcare settings;
- Reflect on prospects and limitations of mRNA-based vaccines for infectious diseases and beyond.

Practical Information

Certificate of Attendance

A certificate of attendance will be sent to you after successfully completing the program and post-workshop survey.

Language

The official language of the workshop is English. Translation will not be provided.

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.

Liability and Insurance

By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Registration

The registration page of this program will open soon.

Fees and Conditions

	Regular Delegates*	Industry**
Standard Fee	€50.00	€95.00

Discounts
Early-Career Investigators / Academia from RLS WITH ACCEPTED ABSTRACT	Complimentary Registration
Early-Career Investigators / Academia from RLS WITHOUT ACCEPTED ABSTRACT	50% Off Standard Fee
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates	50% Off Standard Fee
Members of Endorsing Organization	Contact the Secretariat
Representatives of Sponsoring Industry	Contact the Secretariat

*Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at Gigi.Lam@amededu.com.

Important

We strongly advise that you register early to ensure your registration.
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes

- Access to all scientific sessions;
- Digital workshop pack, including the program;

IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.

Payment

By credit card only: online or by written authorization (see online registration).

Cancellation Policy

In case of cancellation, the following refunds are applicable:

- Cancellation before/on 4 August 2024 : 50% refund (minus an administration fee)

- Cancellation after 4 August 2024: Unfortunately, no refund will be given

If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 25 August 2024. A statement (email/letter) of cancellation must be sent to Virology Education.

Liability and Insurance

By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.

Program

The program for the Leveraging mRNA Technology Workshop 2024 - 1st Quarterly Edition is currently under development and will be announced in due time.

If you would like to view the program for the Leveraging mRNA Technology Workshop 2023, please click here

Starting from September 2024, Quarterly Online Editions Include

mRNA Cancer Vaccines
Delivery of Antibodies and Other Biologics by mRNA
mRNA Delivery Systems
mRNA Vaccines for Respiratory Diseases
Mechanism of Action of mRNA Vaccines
mRNA for Gene Editing and Cell-Based Therapy

Abstracts

Abstract submission portal for the Leveraging mRNA Technology Workshop 2024 will open soon

Abstracts

The Leveraging mRNA Technology Workshop 2024 accepts new original data as well as encored abstracts.
Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
Information regarding the Abstract Category will be provided shortly.

General Guidelines

Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language

Committees

Program Directors

Daniel Kuritzkes, MD

Brigham and Women's Hospital / Harvard Medical School, United States

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Organizing Committee

Anna Blakney, PhD, PEng

Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, Canada

James E. Crowe, Jr., MD

Vanderbilt University Medical Center, United States

Deborah H. Fuller, PhD

University of Washington School of Medicine, United States

Norbert Pardi, PhD

University of Pennsylvania, United States

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Support

Support Our Initiative

Financial backing to the Leveraging mRNA Technology Workshop 2024 helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored support package by contacting Gi Gi Lam at Gigi.Lam@amededu.com or call +31 30 230 7140.

Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

Symposium opportunities
Non-commercial interviews with company representatives
Verbal acknowledgement during the program
Discounted and complimentary registrations for your representatives
Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
Company acknowledgement on printed meeting materials including but not limited to banners and the program book
Digital and printed advertising opportunities
Social media shout-outs
Logo on the conference bag

*Subject to the support level.

Endorsers

Become an Endorser

If you would like your organization to support Leveraging mRNA Technology Workshop 2024 as an endorser or media partner, please contact Ms. Michelle Wu at Michelle.Wu@amededu.com.